Cocktail blood biomarkers: Prediction of clinical outcomes in patients with acute ischemic stroke

European Neurology

Volumn 69, Issue 2, 2013, Pages 68-75

  Zeng, Lili ^a,b   Liu, Jianrong ^a   Wang, Yongting ^b   Wang, Ling ^a   Weng, Suiqing ^a   Chen, Shengdi ^a   Yang, Guo Yuan ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Biomarker; Interleukin 6; microRNA; Prognosis; Stroke

Indexed keywords

BIOLOGICAL MARKER; CD40 LIGAND; D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FRUCTOSE BISPHOSPHATE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA 210; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD CELL; BRAIN ISCHEMIA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GOOD GENERAL CONDITION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POOR GENERAL CONDITION; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL PREDICTION; BLOOD CLOTTING; FIBRINOLYSIS; HEMOSTASIS; INFLAMMATION; OUTCOME ASSESSMENT; PREDICTION; SENSITIVITY AND SPECIFICITY; STROKE PATIENT;

AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CYTOKINES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMOSTASIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STROKE;

EID: 84868686512     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000342896     Document Type: Article

References (41)

1. Whiteley W, Chong WL, Sengupta A, Sandercock P: Blood markers for the prognosis of ischemic stroke: A systematic review. Stroke 2009; 40:e380-e389
2. Foerch C, Montaner J, Furie KL, Ning MM, Lo EH: Invited article: Searching for oracles? Blood biomarkers in acute stroke. Neurology 2009; 73: 393-399
3. Saenger AK, Christenson RH: Stroke biomarkers: Progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem 2010; 56: 21-33
4. Piskunov A: Neuroinflammation biomarkers. Neurochemical Journal 2010; 4: 55-63
5. Manolescu BN, Berteanu M, Dumitru L, et al: Dynamics of inflammatory markers in post-Acute stroke patients undergoing rehabilitation. Inflammation 2011; 34: 551-558
6. Laskowitz DT, Kasner SE, Saver J, Remmel KS, Jauch EC: Clinical usefulness of a biomarker-based diagnostic test for acute stroke: The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke 2009; 40: 77-85
7. Alvarez-Perez FJ, Castelo-Branco M, Alvarez-Sabin J: Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. J Neurol Neurosurg Psychiatry 2011; 82: 986-992
8. Tuttolomondo A, Di Sciacca R, Di Raimondo D, et al: Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: Relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol 2009; 215: 84-89
9. Whiteley W, Wardlaw J, Dennis M, et al: The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke 2012; 43: 86-91
10. Castellanos M, Serena J: Applicability of biomarkers in ischemic stroke. Cerebrovasc Dis 2007; 24(SUPPL1):7-15
11. Suzuki Y, Urano T: Novel situations of endothelial injury in stroke - mechanisms of stroke and strategy of drug development: Novel mechanism of the expression and amplification of cell surface-Associated fibrinolytic activity demonstrated by real-Time imaging analysis. J Pharmacol Sci 2011; 116: 19-24
12. Doyle KP, Simon RP, Stenzel-Poore MP: Mechanisms of ischemic brain damage. Neuropharmacology 2008; 55: 310-318
13. Ekdahl C, Kokaia Z, Lindvall O: Brain inflammation and adult neurogenesis: The dual role of microglia. Neuroscience 2009; 158: 1021-1029
14. Zeng L, Liu J, Wang Y, et al: MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci (Elite Ed) 2011; 3: 1265-1272
15. Sotgiu S, Zanda B, Marchetti B, et al: Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 2006; 13: 505-513
16. Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A, Licata G: Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des 2008; 14: 3574-3589
17. Basic Kes V, Simundic AM, Nikolac N, Topic E, Demarin V: Pro-inflammatory and antiinflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin Biochem 2008; 41: 1330-1334
18. Foca A, Berlinghieri MC, Barreca GS, et al: Kinetics of IL-8, MIP-1 alpha, TNF alpha, IL-1 beta, IL-1ra and IL-10 in human whole blood samples triggered by smooth and rough LPS. New Microbiol 1998; 21: 123-130
19. Eggesbo JB, Hjermann I, Hostmark AT, Kierulf P: LPS induced release of IL-1 beta, IL-6, IL-8 and TNF-Alpha in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL. Cytokine 1996; 8: 152-160
20. Davi G, Tuttolomondo A, Santilli F, et al: CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. J Atheroscler Thromb 2009; 16: 707-713
21. Jin R, Yang G, Li G: Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. J Leukoc Biol 2010; 87: 779-789
22. Shichita T, Sugiyama Y, Ooboshi H, et al: Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 2009; 15: 946-950
23. Wang DD, Zhao YF, Wang GY, et al: IL-17 potentiates neuronal injury induced by oxygen-glucose deprivation and affects neuronal IL-17 receptor expression. J Neuroimmunol 2009; 212: 17-25
24. Kebir H, Kreymborg K, Ifergan I, et al: Human TH17 lymphocytes promote bloodbrain barrier disruption and central nervous system inflammation. Nat Med 2007; 13: 1173-1175
25. Kishimoto T: IL-6: From its discovery to clinical applications. Int Immunol 2010; 22: 347-352
26. Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M: IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2012; 122: 143-159
27. Waje-Andreassen U, Krakenes J, Ulvestad E, et al: IL-6: An early marker for outcome in acute ischemic stroke. Acta Neurol Scand 2005; 111: 360-365
28. Cojocaru IM, Cojocaru M, Tanasescu R, Iliescu I, Dumitrescu L, Silosi I: Expression of IL-6 activity in patients with acute ischemic stroke. Rom J Intern Med 2009; 47: 393-396
29. Ferrarese C, Mascarucci P, Zoia C, et al: Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab 1999; 19: 1004-1009
30. Tarkowski E, Rosengren L, Blomstrand C, et al: Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995; 26: 1393-1398
31. Tuttolomondo A, Di Sciacca R, Di Raimondo D, et al: Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: Relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol 2009; 215: 84-89
32. Rothwell PM, Howard SC, Power DA, et al: Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke 2004; 35: 2300-2305
33. Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ: D-dimer predicts early clinical progression in ischemic stroke: Confirmation using routine clinical assays. Stroke 2006; 37: 1113-1115
34. Lu FM, Lin SY: Effects of FDP and Danshen on renal cortical Na-K-ATPase activity in rats after treatment with renal ischemia and gentamicin. Chin Med J (Engl) 1989; 102: 516-523
35. Malusardi R, Oddone A, Orlandi M, Manzi G: [Fructose-1,6-diphosphate (FDP) in transitory myocardial ischemia induced by atrial pacing]. Minerva Cardioangiol 1988; 36: 439-444
36. Denti L, Annoni V, Cattadori E, et al: Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med 2004; 117: 312-317
37. Rink C, Khanna S: MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics 2011; 43: 521-528
38. Liu DZ, Tian Y, Ander BP, et al: Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 2010; 30: 92-101
39. Chan SY, Loscalzo J: MicroRNA-210: A unique and pleiotropic hypoxamir. Cell Cycle 2010; 9: 1072-1083
40. Hu S, Huang M, Li Z, et al: MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010; 122:S124-S131
41. Whiteley W, Wardlaw J, Dennis M, et al: Blood biomarkers for the diagnosis of acute cerebrovascular diseases: A prospective cohort study. Cerebrovasc Dis 2011; 32: 141-147